ation
(1 in 20 dilution)
To make up a 2.0mg/ml concentration
(1 in 2 dilution)
Volume of 5% dextrose needed (ml)
Total volume (ml; AmBisome plus 5% dextrose)
Volume of 5% dextrose needed (ml)
Total volume (ml; AmBisome plus 5% dextrose)
10
1
30
7.5
142.5
150
7.5
15
25
2
75
18.75
356.25
375
18.75
37.5
40
3
120
30
570
600
30
60
55
4
165
41.25
783.75
825
41.25
82.5
70
5
210
52.5
997.5
1050
52.5
105
85
6
255
63.75
1211.25
1275
63.75
127.5
* Each vial of AmBisome (50mg) is reconstituted with 12ml Water for Injection to provide a concentration of 4mg/ml Amphotercin B.
Any unused product or waste material should be disposed of in accordance with local requirements.
Go to top of the page7. MARKETING AUTHORISATION HOLDER
Gilead Sciences International Limited,
Granta Park,
Abington,
Cambridge,
CB21 6GT.
Go to top of the page8. MARKETING AUTHORISATION NUMBER(S)
PL: 16807/0001
Go to top of the page9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
11 September 1998/24 September 2004.
Go to top of the page10. DATE OF REVISION OF THE TEXT
12/2011